ElastiMed Welcomes Dr. Amir Belson as a Member of the Board of Directors
ElastiMed has appointed Dr. Amir Belson to its Board of Directors. Dr. Belson brings extensive experience in the medical device industry, having founded several successful companies including Neoguide Systems (acquired by Intuitive Surgical), Vascular Pathways (acquired by C.R. Bard), and Zipline Medical (acquired by Stryker). The appointment comes as ElastiMed prepares to bring its innovative compression therapy device to market. The company focuses on developing wearable medical devices for lymphatic and venous disease patients.
ElastiMed ha nominato il Dr. Amir Belson nel suo Consiglio di Amministrazione. Il Dr. Belson porta con sé una vasta esperienza nel settore dei dispositivi medici, avendo fondato diverse aziende di successo tra cui Neoguide Systems (acquisita da Intuitive Surgical), Vascular Pathways (acquisita da C.R. Bard) e Zipline Medical (acquisita da Stryker). Questa nomina avviene mentre ElastiMed si prepara a lanciare sul mercato il suo innovativo dispositivo di terapia compressiva. L'azienda si concentra sullo sviluppo di dispositivi medici indossabili per pazienti affetti da malattie linfatiche e venose.
ElastiMed ha nombrado al Dr. Amir Belson en su Junta Directiva. El Dr. Belson aporta una amplia experiencia en la industria de dispositivos médicos, habiendo fundado varias empresas exitosas, incluyendo Neoguide Systems (adquirida por Intuitive Surgical), Vascular Pathways (adquirida por C.R. Bard) y Zipline Medical (adquirida por Stryker). Esta designación llega en un momento en que ElastiMed se prepara para lanzar al mercado su innovador dispositivo de terapia compresiva. La empresa se enfoca en desarrollar dispositivos médicos portátiles para pacientes con enfermedades linfáticas y venosas.
ElastiMed는 Dr. Amir Belson을 이사회의 일원으로 임명했습니다. Belson 박사는 Intuitive Surgical에 인수된 Neoguide Systems, C.R. Bard에 인수된 Vascular Pathways, Stryker에 인수된 Zipline Medical 등 여러 성공적인 회사를 창립하면서 의료 기기 산업에서 풍부한 경험을 쌓아 왔습니다. 이 임명은 ElastiMed가 혁신적인 압축 치료 장치를 시장에 출시할 준비를 하고 있는 가운데 이루어졌습니다. 이 회사는 림프 및 정맥 질환 환자를 위한 착용 가능한 의료 장치 개발에 주력하고 있습니다.
ElastiMed a nommé le Dr. Amir Belson au sein de son Conseil d'Administration. Le Dr. Belson apporte une vaste expérience dans l'industrie des dispositifs médicaux, ayant fondé plusieurs entreprises prospères telles que Neoguide Systems (acquise par Intuitive Surgical), Vascular Pathways (acquise par C.R. Bard) et Zipline Medical (acquise par Stryker). Cette nomination intervient alors qu'ElastiMed se prépare à lancer son dispositif innovant de thérapie par compression sur le marché. L'entreprise se concentre sur le développement de dispositifs médicaux portables pour les patients atteints de maladies lymphatiques et veineuses.
ElastiMed hat Dr. Amir Belson in seinen Vorstand berufen. Dr. Belson bringt umfassende Erfahrung in der Medizintechnikbranche mit, da er mehrere erfolgreiche Unternehmen gegründet hat, darunter Neoguide Systems (von Intuitive Surgical übernommen), Vascular Pathways (von C.R. Bard übernommen) und Zipline Medical (von Stryker übernommen). Die Ernennung erfolgt, während ElastiMed sich darauf vorbereitet, sein innovatives Gerät zur Kompressionstherapie auf den Markt zu bringen. Das Unternehmen konzentriert sich auf die Entwicklung tragbarer medizinischer Geräte für Patienten mit Lymph- und Venenerkrankungen.
- Strategic appointment of experienced medical device industry leader with successful M&A track record
- Company is advancing towards market launch phase of its compression therapy device
- Leadership addition comes at important commercialization stage
- None.
YOKNEAM,
Dr. Belson is a prominent figure in the medical device industry with extensive experience guiding healthcare companies from early development to commercialization and successful M&A transactions. He founded Neoguide Systems (robotic endoscopy), acquired by Intuitive Surgical in 2009; Vascular Pathways (vascular intervention), acquired by C.R. Bard in 2014; and Zipline Medical (wound closure), acquired by Stryker in 2019. Dr. Belson has also founded other innovative companies, including Venocare, Radiaction Medical, Emboline, Follisave and Modular Surgical.
"I am honored to join ElastiMed as a member of the Board," said Dr. Belson. "ElastiMed is by far the most innovative company in the compression therapy arena. Their wearable medical devices will bring relief to tens of millions of lymphatic and venous disease sufferers around the world and empower them to lead the life they wish rather than being limited by their conditions. I am excited to work with the talented team to drive additional innovation and create impactful solutions for patients and healthcare providers."
Dr. Belson's appointment comes at a pivotal time for ElastiMed as the company is embarking on a quest to bring their device to market. With his proven track record of leadership and entrepreneurship, Dr. Belson will play a key role in guiding ElastiMed through its next phase of growth and development.
"We are thrilled to welcome Dr. Belson to ElastiMed's Board," said Mr. Omer Zelka, Founder & CEO of ElastiMed. "Amir's expertise will be instrumental as we continue to advance our mission of revolutionizing care at home for lymphedema and venous disease patients through wearable technology. Dr. Belson is widely recognized for his contributions to the medical device industry. His commitment to improving patients' outcomes and enhancing healthcare delivery aligns perfectly with ElastiMed's core values."
About Elastimed:
ElastiMed's wearable medical devices are designed to treat and manage lymphatic and venous diseases. With a focus on innovation, ElastiMed designs cutting-edge solutions empowering patients and healthcare providers alike. ElastiMed is dedicated to improving patients' outcomes, addressing health equity challenges and enhancing healthcare delivery at home.
ElastiMed is a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), and has received funding from the Israeli Innovation Authority, Horizon 2020, and private investors.
For more information about Elastimed and its innovative products, please visit www.elastimed.com
Contact:
Omer Zelka
omer@elastimed.com
Photo: https://mma.prnewswire.com/media/2541681/Amir_Belson_Board_Member_ElastiMed.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/elastimed-welcomes-dr-amir-belson-as-a-member-of-the-board-of-directors-302288527.html
SOURCE ElastiMed Ltd.
FAQ
Who is Dr. Amir Belson and what companies has he founded?
What is ElastiMed's main product focus?
What is the strategic timing of Dr. Belson's appointment to ElastiMed?
